Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$149.82M
Total Bought:
$10.55M
Total Sold:
$32.22M
Net Transaction:
-$21.67M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
LENZ Therapeutics, Inc.(LENZ)977,245977,2450$23.20M$28.21M18.83%+$5.01M
Contineum Therapeutics, Inc.CL A(CTNM)800,887800,787-100$15.33M$11.73M7.83%-$3.60M
Eli Lilly and Company(LLY)10,99612,546+1,550$9.74M$9.69M6.46%-$56.3K
UnitedHealth Group Incorporated(UNH)13,12514,625+1,500$7.67M$7.40M4.94%-$275.7K
Gilead Sciences, Inc.(GILD)61,06551,310-9,755$5.12M$4.74M3.16%-$380.2K
Mineralys Therapeutics, Inc.(MLYS)329,513380,883+51,370$3.99M$4.69M3.13%+$698.3K
AbbVie Inc.(ABBV)15,80018,800+3,000$3.12M$3.34M2.23%+$220.6K
Johnson & Johnson(JNJ)25,90022,900-3,000$4.20M$3.31M2.21%-$885.6K
Amgen Inc.(AMGN)7,09012,550+5,460$2.28M$3.27M2.18%+$986.6K
Boston Scientific Corporation(BSX)33,02632,526-500$2.77M$2.91M1.94%+$137.6K
Abbott Labs19,39824,398+5,000$2.21M$2.76M1.84%+$548.1K
Bristol-Myers Squibb Company(BMY)50,00044,000-6,000$2.59M$2.49M1.66%-$98.4K
Thermo Fisher Scientific Inc.(TMO)5,2504,750-500$3.25M$2.47M1.65%-$775.1K
Merck & Co., Inc.(MRK)24,00024,500+500$2.73M$2.44M1.63%-$288.2K
Regeneron Pharmaceuticals, Inc.(REGN)3,4003,4000$3.57M$2.42M1.62%-$1.15M
Stryker Corporation(SYK)7,4506,400-1,050$2.69M$2.31M1.54%-$383.3K
BioNTech SEADS(BNTX)13,15518,950+5,795$1.56M$2.16M1.44%+$596.9K
Medtronic plcSHS(MDT)29,35026,350-3,000$2.64M$2.12M1.41%-$524.6K
argenx SEADR(ARGX)3,9973,430-567$2.17M$2.11M1.41%-$57.2K
Pfizer Inc.(PFE)114,65077,650-37,000$3.32M$2.06M1.37%-$1.26M
Boundless Bio, Inc.(BOLD)678,574678,5740$2.35M$1.97M1.31%-$386.8K
Alnylam Pharmaceuticals, Inc.(ALNY)9,6908,300-1,390$2.67M$1.95M1.30%-$712.0K
BioMarin Pharmaceutical Inc.(BMRN)36,87029,400-7,470$2.59M$1.93M1.29%-$659.1K
Danaher Corporation(DHR)4,7757,275+2,500$1.33M$1.67M1.12%+$343.8K
Neurocrine Biosciences, Inc.(NBIX)12,51511,800-715$1.44M$1.61M1.08%+$168.7K
Intuitive Surgical, Inc.(ISRG)3,0503,0500$1.50M$1.59M1.06%+$93.6K
Vaxcyte, Inc.(PCVX)14,54018,950+4,410$1.66M$1.55M1.04%-$110.2K
Vertex Pharmaceuticals Incorporated(VRTX)4,8403,670-1,170$2.25M$1.48M0.99%-$773.1K
Sarepta Therapeutics, Inc.(SRPT)12,31611,020-1,296$1.54M$1.34M0.89%-$198.2K
Structure TherapeuADS24,39549,250+24,855$1.07M$1.34M0.89%+$265.0K
MoonLake ImmunotherapeuticsCL A(MLTX)27,25823,687-3,571$1.37M$1.28M0.86%-$91.7K
Amicus Therapeutics Inc
COM
141,335135,620-5,715$1.51M$1.28M0.85%-$231.9K
uniQure N.V.SHS(QURE)153,00071,500-81,500$754.3K$1.26M0.84%+$508.4K
Zai Lab LimitedADR(ZLAB)72,87044,800-28,070$1.76M$1.17M0.78%-$585.8K
Cytokinetics, Incorporated(CYTK)28,59324,500-4,093$1.51M$1.15M0.77%-$357.2K
Health Catalyst, Inc.(HCAT)0160,000+160,000$0$1.13M0.76%+$1.13M
Tarsus Pharmaceuticals, Inc.(TARS)11,30020,300+9,000$371.7K$1.12M0.75%+$752.4K
ARS Pharmaceuticals, Inc.(SPRY)98,640106,007+7,367$1.43M$1.12M0.75%-$311.9K
Blueprint Medicines14,92012,560-2,360$1.38M$1.10M0.73%-$284.6K
Arcus Biosciences, Inc.(RCUS)75,52269,552-5,970$1.15M$1.04M0.69%-$119.1K
Privia Health Group, Inc.(PRVA)052,000+52,000$0$1.02M0.68%+$1.02M
CVS Health Corporation(CVS)25,50022,000-3,500$1.60M$987.6K0.66%-$615.9K
Legend Biotech CorporationADS(LEGN)27,20029,800+2,600$1.33M$969.7K0.65%-$355.8K
AstraZeneca PLCADR(AZN)21,34014,650-6,690$2.47M$959.9K0.64%-$1.51M
Clover Health Investments, Corp.CL A(CLOV)0275,000+275,000$0$866.3K0.58%+$866.3K
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
15,2008,000-7,200$1.53M$802.6K0.54%-$728.5K
Inari Med Inc25,00015,153-9,847$1.03M$773.6K0.52%-$257.4K
The Cigna Group(CI)02,250+2,250$0$621.3K0.41%+$621.3K
Iovance Biotherapeutics, Inc.(IOVA)081,500+81,500$0$603.1K0.40%+$603.1K
Biogen Inc.(BIIB)6,0273,852-2,175$1.17M$589.0K0.39%-$579.2K
Illumina, Inc.(ILMN)5,7454,370-1,375$749.2K$584.0K0.39%-$165.2K
Edwards Lifescience25,8507,850-18,000$1.71M$581.1K0.39%-$1.12M
Arvinas, Inc.(ARVN)45,83030,150-15,680$1.13M$578.0K0.39%-$550.8K
Cogent Biosciences, Inc.(COGT)84,40073,800-10,600$911.5K$575.6K0.38%-$335.9K
Summit Therapeutics Inc.(SMMT)26,70030,000+3,300$584.7K$535.4K0.36%-$49.4K
Engene Holdings Inc
COM
94,21978,919-15,300$621.8K$524.8K0.35%-$97.0K
Insmed Incorporated(INSM)9,6817,371-2,310$706.7K$508.9K0.34%-$197.8K
Rocket Pharmaceuticals, Inc.(RCKT)43,38340,183-3,200$801.3K$505.1K0.34%-$296.2K
Intra Cellular Thera6,4304,900-1,530$470.5K$409.2K0.27%-$61.2K
Roivant Sciences Ltd.SHS(ROIV)45,12734,500-10,627$520.8K$408.1K0.27%-$112.6K
Humana Inc.(HUM)2,1811,581-600$690.8K$401.1K0.27%-$289.7K
BeOne Medicines AGADR(ONC)2,6372,010-627$592.0K$371.3K0.25%-$220.8K
Olema Pharmaceuticals, Inc.(OLMA)65,98061,650-4,330$787.8K$359.4K0.24%-$428.4K
BridgeBio Pharma, Inc.(BBIO)15,08511,500-3,585$384.1K$315.6K0.21%-$68.5K
Medpace Holdings, Inc.(MEDP)1,086830-256$362.5K$275.8K0.18%-$86.8K
PTC Therapeutics, Inc.(PTCT)7,6005,800-1,800$282.0K$261.8K0.17%-$20.1K
Turnstone Biologics517,648517,6480$288.4K$257.2K0.17%-$31.2K
Ionis Pharmaceuticals, Inc.(IONS)9,4407,200-2,240$378.2K$251.7K0.17%-$126.5K
Vera Therapeutics, Inc.CL A(VERA)7,4285,700-1,728$328.3K$241.1K0.16%-$87.3K
Crinetics Pharmace5,8004,400-1,400$296.4K$225.0K0.15%-$71.4K
Geron Corporation(GERN)46,00063,500+17,500$208.8K$224.8K0.15%+$15.9K
Ascendis Pharma A/SADR(ASND)2,1411,600-541$319.7K$220.3K0.15%-$99.4K
Jazz Pharmaceuticals plcSHS USD(JAZZ)2,2741,750-524$253.3K$215.5K0.14%-$37.8K
Revolution Medicines, Inc.(RVMD)6,4304,900-1,530$291.6K$214.3K0.14%-$77.3K
United Therapeutics Corporation(UTHR)1,060595-465$379.9K$209.9K0.14%-$169.9K
Springworks Therapeu10,0105,500-4,510$320.7K$198.7K0.13%-$122.0K
Viatris Inc.(VTRS)25,64015,600-10,040$297.7K$194.2K0.13%-$103.5K
Novo Nordisk A/SADR(NVO)2,2002,2000$262.0K$189.2K0.13%-$72.7K
Royalty Pharma plcCL A(RPRX)16,4307,200-9,230$464.8K$183.7K0.12%-$281.1K
Moderna, Inc.(MRNA)13,9604,350-9,610$932.9K$180.9K0.12%-$752.1K
Madrigal Pharmaceuticals, Inc.(MDGL)1,045570-475$221.8K$175.9K0.12%-$45.9K
Incyte Corporation(INCY)02,500+2,500$0$172.7K0.12%+$172.7K
Cargo Therapeutics08,500+8,500$0$122.6K0.08%+$122.6K
Exelixis, Inc.(EXEL)11,0103,500-7,510$285.7K$116.5K0.08%-$169.2K
Axsome Therapeutics, Inc.(AXSM)0820+820$0$69.4K0.05%+$69.4K
Io Biotech Inc075,000+75,000$0$69.0K0.05%+$69.0K
Apellis Pharmaceutic
COM
10,3000-10,300$297.1K$0—-$297.1K
DexCom, Inc.(DXCM)10,7000-10,700$717.3K$0—-$717.3K
Evolent Health, Inc.CL A(EVH)39,0000-39,000$1.10M$0—-$1.10M
GoodRx Holdings, Inc.(GDRX)116,0000-116,000$805.0K$0—-$805.0K
IQVIA Holdings Inc.(IQV)7,6000-7,600$1.80M$0—-$1.80M
Perspective Therapeutics, Inc.(CATX)20,4000-20,400$272.3K$0—-$272.3K
Iteos Therapeutics15,6500-15,650$159.8K$0—-$159.8K
J P Morgan ExchangeULTRA SHRT ETF
ULTRA SHRT ETF
2,5000-2,500$126.8K$0—-$126.8K
Kyverna Therapeutics, Inc.(KYTX)22,9000-22,900$112.0K$0—-$112.0K
Option Care Health, Inc.(OPCH)40,0000-40,000$1.25M$0—-$1.25M
Zimmer Biomet Holdings, Inc.(ZBH)13,5000-13,500$1.46M$0—-$1.46M
ICON Public Limited CompanySHS(ICLR)4,6080-4,608$1.32M$0—-$1.32M
ADC Therapeutics SASHS(ADCT)36,2140-36,214$114.1K$0—-$114.1K
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q4 2024 | TickerTrail